CKB and colorectal carcinoma: Subclones of CRC which exhibit miR-483-5p/miR-551a silencing and creatine kinase brain-type (CKB) overexpression are able to secrete CKB into the hepatic micro-environment, where hepatocyte derived creatinine can be converted to phosphocreatine.